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the LA during atrfal contraction followed by repid LAA filling in aystole; less
repid IAAemptying during early diastolic LVfilling; oscillatory LAAflow in mid-
dieetoleas LAand LVpressurea crossover.We simulated three cliniealstates:
normal LAAcontraotion, inactive LAA (“stunned” LAAaftercardioveraion from
fibrillation to sinus rhythm), andno LAAatall. Wecalculatedcerdiac index(Cl,
l/mirVm2),earty-diastolic and Iate-diaatolic ME (MF-E and MF-A, ml/s), and
mean LAP (mmHg). Loss of LAA contraction reduces MF-A and increaaes
MF-E by elevating IAP. Of note, the inactive LAA produces the least efficient
atrioventricular blood transfer with lowest Cl and highest mean LAP - leas
efficient hemodynamica than either a normal LAA or no LAA at all. Thus,
a properfy-timed left atrial appendage contraction improves left ventricular
filling dynamics and minimizea left atrial preasure.
c1 MF-E MF-A MLAP
Normal I-M 1.30 54 90 2.5
InacflveLAA 1.23 104 86 3.3
Absent LAA 1.34 49 e4 2.4
n = 6). The density (Bmex) and affinity (Kd) of SR Ca2+ release channels
were determined using [3H]ryonadine binding. Thapeigargin-sensitive Ca2+
ATPase activity (~mol Pi releaaetimitimg protein) and tissue protein level
were determined in isolated SR fraction. Ca2+ ATPase protein level was
quantified in densitometric unite/5 pg protein.
IDC ICM
Bmax (fmolJmgprotein) 1212 +32 859 + 54*
Kd (nM) 1.5 i 0,2 1.2 * 0.3
Ca2+ ATPase activity 0.15 l 0.01 0.11 l 0.01”
Ca2+ ATPass IDrotein) 2.6 + 0.4 0.8 +0.3*
*P <0,05 JDCVS. ICM
The results indicate that Bmex of SR Ca2+ release channels ia reduced
in ICM compared to IDC without changes in Kd. Ca2+ ATPase activity and
protain level are also lower in ICM compared to IDC. Conclusions: In failed
explanted human hearts, SR Ca2+ transport is impaired in ICM compared to
IDC. The presence of abnormalities of cardiac SR Ca2+ transpon in heart





J. Demellis, C. Stefanadis, E. Tsiamis, C. Stratos, C. Toutouzas,
C. Piteevoa, P.Toutouzes. Department of Cardiobgx Hippokration Hospital,
University of Athens, Greace
In the traditional separation of “left atrial” (IA) function resewoir, conduit
and pump functions are included. A method such as pressure-volume (p-v)
analysia that integrates data from the entire cardiac cycle can evaluate LA
performance in physiologic investigation. We have applied real-time two-
dimenaional eohocerdiographic imaging with automatic boundary detection
(ABD) to the accurately estimation of LA volume changes simultaneously
with a Millar’s catheter-tip micromanometer introduced retrogredely into the
LA via the mitral valve to obtain the U pressure, using a steerable cardiac
catheter. Six normal subjects during atrial pacing at hearl rate levels equal
to those expected after dobutemine administration, were studied. LA end
diastolic volume (V,) was measured at the volume immediately preceding
atrial shortening following the P wave of the electrocardiogram. The LA p-
v relation was composed of two loops: the A loop, expressing the pump
function of the left atrium and the V loop, expressing the reservoir function
of the m. Preasure and volume data during the ascendinglimbof the V IOOP
were fitted to the exponential function, P = bxe’.v, where P = pressure, V =
volume, a waa the pesaive elastic chamber stiffness constant (mm-’) and
b was the elastic constant (mmHg). A significant increase in area of A loop
(from 163 to 286 mLmmHg, p < 0.001) and in area of V loop (from 42 to
264 ml.mmHg, p < 0.001) was found. The difference between the area of A
loop and the area of V Imp (net atrial work) expressing the energy added
by the tA to ifs contents significantly decreased from 121 to 34 mLmmHg,
p <0.001. Furthermore, there was an improvement of LA diastolic function
es the diastolic p-v plot waa diaplaced downward and the a decreased (from
0.0166 to 0.0036 mm-’, p < 0.001). Conclusion: In normal hearts LA pump
function and LA distensibility may acutely increase with inofropica while
IA contribution to left ventdcular filling may acutely decrease by means of
myooerdial function improvement.
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m1016149 CalciumTranaportie Impairedin SarcoplaamicReticuiumof FaiiedHumanHeartsDueto
IschemicCardiomyopathyComparedto
IdiopathicDilatedCardiomyopathy
R.C. Gupta, V.G. Sharov, N. Silverman, M. Leach, S. Goldstein,
H.N. Sabbeh. fferrry Ford Heart and Vascu/arhrstitute, Detroit, M/, USA
Recent studies have shown that aarmplasmic reticulum (SR) Ca2+ trana-
port ia unchanged in human idiopathic dilated cardiomyopethic (lDC) hearts
compared to normal hearts. We compared SR Ca2+ release channel density
and Ca2+ ATPaee activity and protein level in LV tissue of explanted failed
human hearts due to IDC (n = 6) and to ischemic cardiomyopathy (lCM,
m Abnormal intracellularCalcium Reapo.wto
increasedFrequencyof Stimulationin Failing
HumanHearts
R.J. Hajjar, P.Helm, U. Schmidt, T.G. DiSalvo, J.K. Gwathmey. Boston
Univeraify School of Medicirre, Boston, MA, USA, Massachusetts Gene~\
Hospital, Boston, MA, USA
Human heart failure is characterized by abnormal intracellular calcium han-
dling, decreased sarcoplasmic reticulum Ca2+-ATPaseactivity andan abnor-
mal force-frequency relationship. To assess whether abnormal intracellular
Ca2+ mobilization flCa2+]l) release or uptake by the SR contributes to the
negative force-frequency relationship in failing human hearts, we evaluated
the frequency response of [Ca2+]l, measured with the bioluminescent protein
aequorin, in electrically driven trebeculae from the left ventricles of 6 failing
(F) and 5 non-failing (NF) human hearts at 37QC.In NFtrabeculae, increasing
frequency of stimulation from 0.1 to 2.0 Hz increased the force of contraction
(FOC) (% A = 98 + 11%) and peak [Ca2+]i (1.3 + 0.1 to 1.6 + 0.2 Kmovl)
whila shortening the relaxation phaae of the [Ca2+]i transient (L6u%:time to
80% relaxation of the [Ca2+]l signal: 116+ 13 to 92 + 9 msec). In F trabeou-
Iae increasing frequency of stimulation from 0.1 to 1.0 Hz increased the FOC
(% A =67+ 13%) and peak [Caz+]i (1.2 + 0.1 to 1.7 ~ 0.2 ~mol/1) while
& remained unchanged (167+ 14 to 183 + 18 msec). Further irrcraaaea
of the stimulation frequency from 1.0 to 2.0 Hz decreased the FOC (% A =
–56 + 9%) and peak [Ca2+]i (1.7 + 0.2 to 0.6 + 0.2 ymol/1) while signifi-
cantly prolonging LWM(163 + 16 to 274 + 21 msec). We conclude that 1)
abnormal intracellular calcium contributes to the abnormal force-frequency
relationship observed in F hearts, and 2) depressed SR Ca2+ATPaaeactivity
in F myocerdium leads to abnormal Ca2+ uptake and loading of the SR at
high frequencies of stimulation
1016-151 Downregulationof theCaicium-bindingProtein




A. Remppis, P.Ehlermann, C.W. Heizmann H.A. Katus. Med. K/irrik//,
University of Liilmck, Germany, 1Clinical Chemistry Department of
Pediatrics, University of Ziirich, Switzerland
hrtroduction: The calcium-binding protein SIOOA1 has been shown to stim-
ulate the Ca2+-induced Ca2+-release. Since an altered regulation of the SR
Ca2+-release-channelmight account foradeoreased Ca2+-releaseobeemd
in human end atage heart failure, we hypothesized that a change in S1OOAI
gene-expression might correlate with this finding. Methods: Left ventricular
tissue from patienta with end stage heart failure was investigated (coronary
heart disease: n =6; dilative cardiomyopathy: n = 6) and compared to control
specimen (n = 3) deriving from donor hearts. After EDTA-extreotion Ca2+-
binding proteina (CaBP) were prepurified byoctylsepharose chromatography
and finally fractionated by reverse-phase HPLC (RP 300, C8). The eluting
CaBP were identified by ESI-MS and S1OOA1quantified by a peak integra-
tor. Reeulfs: While ESI-MS analyses revealed identical molecular masaea
for SIOOAI in failing hearts and controls (10460Da), integration of eluting
SIOOA1 peaks documented a significantly lower protein concentration in all
myopathic samples yielding two groups with either < 75% (69 * 6Yo)or
< 35% (23 + 12%) as compared to controls (100 + 8%, p < 0.001). No
correlation wea seen with the underlying disease. Conclusion: in human car-
diomyopathy SIOOAI protein levels are significantly downreguiated, while
unchanged molecular masses exclude a differential posttranslational pro-
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cessing in failing hearts. This finding might explain the altered Ca2+-release
from SR as obseivad in human end stage heart failure.
I1016-152I Relative Expression of Ca~dia~T~~p~ninT
Isoforms in Control snd Fsiling Humsn Left
Ventricles
L. Mesnard, J.-J. Mercsdier, D. Logeart, M. Heimburger, G. Butler-Browne,
F.Samson. Facult4 de M6decine de Parfs-Sud, CNRS URA 1159,Le
Plessis Robinson, France, CNRS URA 1448, Paris, Frarrca
Tropcnin Tisa protein of the thin filament of thesarcomere which participates
in the regulation of actin-myosin interaction. We and others have cloned pre-
viously several cDNAs of human cardiac TnT (cTnT) which demonstrated
the multiplicity of cTnT isoforms in the human heart. Four of these isoforms
named TnTl, 2, 3 and 4 result from a combinatorial alternative inclusion of
a 30 and a 15 nt sequence in the 5’ coding region of the cDNAs. In failing
human ventricles, an increased expression of TnT4 has been reported at
the protein level and more recently, RT-PCR experiments showed increased
expression of fetal-type splicing producte in the 5’ region, one of them cor-
responding to TnTl. To clarify this ieeue, we examined the accumulation of
the four TnT mRNA species in 13 failing and 8 control adult left ventricles
using RNaee protection assay and Western blotting. At the mRNA level, the
four iscforms were detected in all samples: TnT3 was the major isoform,
TnT4 a minor isoform and TnTl and 2 were barely detected. At the protein
level, TnT3, 4 and 1 were detected with the same relative abundance as
that seen at the mRNA level. In addition, we detected a fourth TnT species
of faster electrophoretic mobility which could correspond either to a skeletal
TnT isoform or to a short cTNT isoform. We obsenfed a significant increase
in the level of TnT4 mRNA and protein expression in only half of the failing
ventricles compared to controls. At the protein level, TnTl relative abun-
dance wasdeoreased in all the failing samples studied compared to controls.
Conclusion: TnT4 expression in human ventricles seems more related to
individual variations than specific for left ventricular failure; a decrease in
TnTl relative expression maybe more specific for left ventricular failure.
H1016153 Beneflcisi Effects of imidsprii on Csrdisc
Ssrcopissmic Reticuium Ce2+-Pumpand Gene
Expre&ion inCongestiveHeartFaiiurein Rsts
Q. Shao, B. Ren, N. Takada, N.S. Dhalla. Institute of Cardiovasctdar
Sciences, St. Boniface Hospital Research Centre, Universifyof Manitoba,
Winnipeg, Caneda
Angiotensin converting enzyme (ACE) inhibitors are known to improve csr-
diac function in congestive heart failure; however, very little is known if this
effect is associated with similar changes in the subcellular and molecular
mechanisms for Ca2+-handliflg. Since impairment of the sarcoplasmic retic-
ular (SR) Caz+-transporl in the failing hearl plays a critical role in contractile
dysfunction, we examined the effects of a new ACE inhibitor, imidapril, on
the SR Ca2+ transport and gene expression of the Ca2+ pump ATPeee
(SERCA2) in failing hearts due to myooerdial infarction. In this study heart
failure was induced in rats by occluding the coronary artery for 7 weeks;
sham-operated animals served as controls. Both control and experimental
animals were either given imidapril (1 mgik~day) or the vehicle for period of
4 weeks starting at 3 weeks after the coronary occlusion. Hemodynamic as-
sessment revealed a 4-fold increase in left ventricular end diastolic pressure
(LVEDP) whereas the rate of mntraction (+dP/dt) and the rate of relaxation
(-dP/dt) were decreased by58 +3.4 and 82 +2.3% in the infarcted animals,
respectively. The LVEDP in the imidapril-treated animals was increased by
1.8-fold whereas +dP/df and –dP/df were decreased by 20 * 2.1 and 16+
1.8%, respectively.The SRCa2+ uptake wasdepressad by50t065%and 15
to 26% in the untreated and imidapril-treatad infarcted animale, respectively;
the SR Ca2+-pump ATPase activities in the control, untreated-infarcted and
treated-infarcted groups were 13.8 * 1.3, 5.8 + 1.8 and 11.0 + 1.2 &mol
Pi/m@hr.Western blot analysis revealed a 25% decrease in the Ca2+pump
protein in the infarcted animais; this change was completely prevented by
imidaprfl. The SERCA2 mRNA levels were reduced by 50 * 4.5 and 18 *
2.3% in the untreated and treated infarct groups, respectively.These resulte
suggestad that ACE inhibitor’ssuch as imidapril may increase the abundance
of mRNA for SR proteins and thus may prevent the depression in SR Ca2+-
transport andaescoiatsd Cardiacdysfunction in animals with congestive heart
failure.
11016-154I ANoveiCaicium Promoter improves isotropic
State and Mechanical Efficiency in Conscious
Dogs with Heart Faiiure
M. Uechi, N. Sate, K. Asai, R. Kudej, S.F.Vatner. The Department of
Medicine, Harvard Medical School, The New England Regional Primate
Rasaarch Centec Southborough, MA 01772, USA, Brigham & Womerr’a
Hospital, Boston, MA 02115, USA
Traditional inotropic agente, e.g., those that increase myooardial contraction
through enhanced cyclic AMP at relatively high 02 cost are frequently not
useful in the clinical setting, in part, because mechanical efficiency is not
improved. The goal of this study was to evaluate the effects of a new agent,
i.e., a calcium promoter, BAY y 5959, in 11 conscious dogs, chronically
instrumented for measurement of left ventricular (LV) and arterial pressures,
LVdiameter, wall thickness, coronary blood flow, cardiac output, and arterial
and corona~ sinus Oz before and after heart failure (HF) was induced by
rapid pacing (240 b/rein x 4 wks). Heart rate fell with BAY y 5959 similarly
before (31 + 3%) and after (–33 + 5%) HF. LV dP/dt increased with BAY y
5959 similarly before (72 + 6%) and after HF (69 + 10’Yo).Cardiac output
rose with BAY y 5959 more (p -=0.05) after HF (45 + 7%) than before HF (7
+ 3%). Mechanical efficiency, calculated from cardiac output, pressures and
MVO*, fell (p < 0.05) in HF (from 0.56+ 0.06 to 0.23 + 0.04). BAY y 5959
increased efficiency more (p < 0.05) after HF (0.18 + 0.04) than before HF
(0.06 + 0.03). Thus, the calcium promoter, BAY y 5959, increases inotropic
state and cardiac output in HF, but most importantly increases mechanical
efficiency, making this agent potentially desirable for clinical applications
Whereinotropic support is indicated.
EiEl Treatment Choicea in Heart Faiiure: Coat,
Utilization, and Outcome




Congestive Heart Faiiure at an Academic. –
Medicai Center: 1990-1995
M.W. Rich, K. Brooks, P.Luther. Washington University School of Medicine
and the St. Louis College of Pharmacy, St. Louia, MO, USA
To determine the impact of recent clinical tnale and publiehed,guidelines on
the management of congestive hearl failure (CHF) at an academic medical
center, discharge medications in patients (PTS) hospitalized with a primary
diagnosis of CHF in 1990 (N = 109) and 1995 (N = 168) were compared. All
PTS had an echocardiogram and separate analyses were performed in PTS
with impaired (estimated EF c 45%) vs. preserved (EF z 45%) LV aystolic
function.
Resu/ta:The median age was 74 yre, 37.3% were male, and 45.1% were
white. Discharge medications in PTS with eyetolic dysfunction included:
1990 (N= 47) 1995 (N= 108) P
Digoxin 44.7”/0 50.9”/. NS
Diuretic 83.O”A 84.3% NS
ACE inhibitor 7e.7”h 89.e% 0.11
Optimaldose* 24.3”A 81.5% <0,001
Calciumblocker 21.3”A 25.9 ”/o NS
Beta blocker 2.1”/. 15.7”/0 0.031
ACEIor nitrates/hydrsl 80.94A 95.4”/. 0.009
. z targetdow in publishedtrials
Inpatients with presenmd LV function, the use of both ACE inhibitors
(33.9% vs. 52.5%, p = 0.041) and beta blockers (4.8% vs. 23.6%, p = 0.004)
increased significantly from 1990-1995.
Conclusions: In accordance with published guidelines, over gs~o of PTS
with systolic CHF were receiving an ACE inhibitor or hydralazine/nitrates in
1995, a significant increase from 1990. The propotlion of PTS on optimal
dose ACE inhibitore increased 2.5-fold, and there was a 7.5-fold increase in
the use of beta blockers. The use of ACE inhibitors and beta blockers also
increased in PTS with CHF and preserved systolic function. The use of other
medications, including digoxin, did not change during this period.
